<?xml version="1.0" encoding="UTF-8"?>
<p>Influenza virus is the most important pathogen that causes acute lower respiratory infections (
 <xref rid="ref-62" ref-type="bibr">WHO, 2018b</xref>). The OST, a neuraminidase inhibitor, is the main anti-influenza used in clinics, but strains resistant to this molecule have been in clinical treatments reported worldwide, mandating the development of novel therapeutics (
 <xref rid="ref-10" ref-type="bibr">Dixit et al., 2013</xref>; 
 <xref rid="ref-27" ref-type="bibr">Lopes e Souza et al., 2015</xref>; 
 <xref rid="ref-54" ref-type="bibr">Souza et al., 2011</xref>).
</p>
